A5042224614- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- COVID-19 Clinical Research Studies
- Clinical Laboratory Practices and Quality Control
- Biosensors and Analytical Detection
- Vaccine Coverage and Hesitancy
- Advanced biosensing and bioanalysis techniques
- Heparin-Induced Thrombocytopenia and Thrombosis
- Monoclonal and Polyclonal Antibodies Research
- Animal Virus Infections Studies
- Respiratory viral infections research
- Long-Term Effects of COVID-19
- COVID-19 epidemiological studies
- Renal function and acid-base balance
- COVID-19 diagnosis using AI
- Influenza Virus Research Studies
- Thermal Regulation in Medicine
- Body Composition Measurement Techniques
- Hepatitis B Virus Studies
- Hemodynamic Monitoring and Therapy
- vaccines and immunoinformatics approaches
- Intramuscular injections and effects
- Artificial Intelligence in Healthcare and Education
- Infection Control and Ventilation
- Viral gastroenteritis research and epidemiology
University of Verona
2021-2025
Casa di Cura Villa Garda
2021-2023
Provincia Autonoma di Trento
2023
ORCID
2023
Universität Innsbruck
1989
Background: This study monitored total anti-SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) RBD (receptor-binding domain) antibodies levels in a large population of healthcare workers undergoing mRNA COVID-19 vaccination. Methods. The consisted employees Pederzoli Hospital Peschiera del Garda (Verona, Italy), who underwent voluntary vaccination with two doses BNT162b2 (Comirnaty; Pfizer Inc). Venous blood was drawn immediately before the first vaccine dose, as well 21 days...
Crystals in urinary sediment are commonly recognized structures, typically identified by a combination of crystal morphology and urine pH. In this paper, we present the first reported case EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidene) crystals, primary metabolite methadone, 67-year-old male with hepatorenal syndrome. Routine urinalysis revealed numerous needle-shaped which prompted further investigation. Advanced techniques, including Raman spectroscopy mass spectrometry,...
Abstract Objectives Since universal vaccination is a pillar against coronavirus disease 2019 (COVID-19), monitoring anti-SARS-CoV-2 neutralizing antibodies essential for deciphering post-vaccination immune response. Methods Three healthcare workers received 30 μg BNT162b2 mRNA Covid-19 Pfizer Vaccine, followed by second identical dose, 21 days afterwards. Venous blood was drawn at baseline and serial intervals, up to 63 afterwards, assessing total immunoglobulins (Ig) anti-RBD (receptor...
The current study was designed to evaluate the analytical performance of new Mindray highly sensitive cardiac troponin I (hs-cTnI) chemiluminescent immunoassay on CL-1200i, as a thorough validation novel hs-cTnI methods is required before introduction into clinical practice.
Background. This study monitored total anti-SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) RBD (receptor binding domain) antibodies levels in a large population of healthcare workers undergoing mRNA COVID-19 vaccination. Methods. The consisted the employees Pederzoli Hospital Peschiera del Garda (Verona, Italy), who underwent voluntary vaccination with two doses BNT162b2 (Comirnaty; Pfizer Inc). Venous blood was drawn before first vaccine dose, and 21 (before second dose) 50...
This study aimed at monitoring the kinetics of serum total anti-SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) antibodies in a cohort healthcare workers after voluntary vaccination with Pfizer-BioNTech disease 2019 (COVID-19) mRNA-based vaccine.
Background: Most studies on immune response after coronavirus disease 2019 (COVID-19) vaccination focused serum IgG antibodies and cell-mediated immunity, discounting the role of anti-SARS-CoV-2 neutralizing IgA in preventing viral infection. This study was aimed to quantify mRNA COVID-19 baseline SARS-CoV-2 seronegative healthcare workers. Methods: The population consisted 181 SARSCoV-2 workers (median age 42 years, 59.7% women), receiving two doses Pfizer vaccine BNT162b2 (Comirnaty)....
We provide here an updated analysis of ongoing serosurveillance study, presenting data on the effect a third dose Pfizer/BioNTech BNT162b2 vaccine serum anti-SARS-CoV-2 IgG antibodies.We tested baseline SARS-CoV-2 seronegative healthcare workers undergoing primary vaccination with mRNA-based COVID-19 Comirnaty vaccine, followed by administration homologous booster (third dose). Venous blood was collected before either vaccination, at 1, 3 and 6 months afterwards, as well 1 month after...
Since universal vaccinations represents the most effective strategy to mitigate coronavirus disease 2019 (COVID-19), baseline assessment and post-vaccine monitoring of anti-SARS-CoV-2 neutralizing antibodies are essential vaccination programs. Therefore, this study aimed compare data five commercial anti-SARS-CoV2 immunoassays after administration an mRNA vaccine.Venous blood was collected from three healthcare workers, receiving a double (30 g) dose BNT162b2 Covid-19 vaccine (Comirnaty,...
Due to the large volume of tests needed in a relatively short time for screening and diagnosing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, antigen immunoassays may provide potential supplement molecular testing. This study was aimed assess clinical preference DiaSorin LIAISON SARS-CoV-2 Ag chemiluminescence immunoassay.
Abstract Objectives This study investigated the feasibility and clinical value of using a novel, automated high-throughput SARS-CoV-2 Interferon Gamma Release Assay (IGRA), combined with total anti-SARS-CoV-2 antibodies assessment, for evaluating immune response after bivalent BNT162b2 vaccination. Methods A cohort healthcare workers, who already underwent primary vaccination boosting monovalent vaccine, received booster dose new formulation. Blood samples were taken immediately before (T0)...
Abstract Background Since universal vaccination is a pillar against coronavirus disease 2019 (COVID-19), monitoring anti-SARS-CoV-2 neutralizing antibodies essential for deciphering post-vaccination immune response. Methods Three healthcare workers received 30 μg BNT162b2 mRNA Covid-19 Vaccine, followed by second identical dose, 21 days afterwards. Venous blood was drawn at baseline and serial intervals, up to 63 afterwards, assessing total immunoglobulins (Ig) anti-RBD (receptor binding...